Pediatric and neonatal cardiovascular pharmacology

Area of Science:

• Pediatric Cardiology
• Congenital Heart Disease
• Pediatric Critical Care

Background:

• Significant advancements in cardiology, surgery, and postoperative care have improved survival for neonates and children with complex congenital cardiac anomalies.
• Complete surgical repair is increasingly the standard of care, shifting focus to comprehensive pre- and postoperative management.

Purpose of the Study:

• To emphasize the critical role of collaborative management and medication understanding in caring for pediatric patients with congenital heart anomalies.
• To review cardiac anatomy, physiology, and developmental changes relevant to medication administration.
• To provide a concise overview of essential pre- and postoperative medications used in pediatric cardiac intensive care.

Main Methods:

• Review of current literature on pediatric congenital heart anomaly management.
• Analysis of the impact of advancements in surgical techniques and postoperative care.
• Synthesis of information on cardiac anatomy, physiology, and pharmacology relevant to pediatric critical care.

Main Results:

• Complete repair is now common for complex congenital heart anomalies, necessitating expert pre- and postoperative care.
• Nurses' understanding of cardiac function and developmental changes enhances medication management.
• Knowledge of specific pre- and postoperative medications and their cardiovascular effects is vital for safe administration in the PICU/NICU.

Conclusions:

• Improved survival rates in pediatric congenital heart anomaly patients are driven by technological advancements and, crucially, by meticulous postoperative care.
• A thorough understanding of cardiac principles and medications is essential for nurses in the Pediatric Intensive Care Unit (PICU) and Neonatal Intensive Care Unit (NICU).
• Collaborative management and precise medication administration are key to optimizing outcomes for these vulnerable patients.